Evigrade

Cetylpyridinium

AEMPS

Cationic quaternary ammonium antiseptic for topical use in the mouth and throat

ATC code: R02AA06

Brand names: Cepacol

Updated · Methodology

Indications

C

Sore throat

Adjunct

Cetylpyridinium is the antiseptic in throat lozenges, and in Spain that means Septolete first of all, where it comes with benzydamine. The AEMPS ficha técnica describes the indication as short-term local anti-inflammatory, analgesic and antiseptic treatment of throat, mouth and gum irritation in adults, adolescents and children over 6 years, for up to 7 days. The analgesic part of the effect rests on benzydamine, the antiseptic part on cetylpyridinium. The lozenge is dissolved slowly every 3 to 6 hours, no more than 3 to 4 a day. One limit from the ficha matters: if there is no noticeable improvement within 3 days or fever appears, the situation is reassessed. Prolonged use of topical antiseptics causes sensitization, and treatment is then stopped.

ICD-10: R07.0

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

F

COVID-19 prevention

Not recommended

Since 2020 cetylpyridinium has been sold as protection against coronavirus: a mouthwash or lozenge «kills the virus in the mouth». In a test tube a cationic antiseptic does destroy the lipid envelope of the virus, yet that gives a person no protection from infection. The 2020 Cochrane review of gargling and nasal sprays for healthcare workers during aerosol-generating procedures found emptiness on this question: there are no studies showing a reduction in infections. The questions and answers on COVID-19 do not list gargling as a preventive method. Protection comes from vaccination, ventilation and a mask in crowded places, not from a throat lozenge. If a cetylpyridinium mouthwash was sold as COVID-19 prevention or as «clearing viruses», consider seeking a second opinion.

ICD-10: Z25.8 · ICD-11: QC01.9

F

Immune support and respiratory infection care

Not recommended

The second marketing line for antiseptic lozenges is «immune support and cold prevention in autumn». Cetylpyridinium does nothing to immunity: it is a surfactant that destroys microbial membranes where it lands and is washed away by saliva in 20 to 30 minutes. There are no prevention studies in which regular lozenge use lowered the rate of respiratory infections, and the AEMPS ficha técnica limits use to seven days and only for throat irritation already present. Continuous use of a topical antiseptic is not harmless: the ficha names sensitization and mucosal burning. The number of respiratory infections falls with enough sleep, hand washing and influenza vaccination. If antiseptic lozenges were offered as a course «for prevention», consider seeking a second opinion.

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

A quaternary ammonium compound with a long hydrocarbon tail: the positively charged head is drawn to the negatively charged surface of a bacterial cell, the tail inserts into the membrane, the membrane loses integrity and the cell contents leak out. The spectrum covers gram-positive bacteria, some gram-negative ones, Candida species and enveloped viruses. Cetylpyridinium acts only on the mucosa it reaches and goes no deeper: a lozenge holds the concentration in the mouth for a few tens of minutes before saliva washes it away. Hence the schedule – every 3 to 6 hours – and the 7 day ceiling: throat inflammation in a cold is caused by a virus, while the antiseptic works on surface microflora.

Safety

Contraindications

  • Hypersensitivity to cetylpyridinium
  • Children under 6 years because of the dosage form
  • Concurrent use with anionic compounds, for example lauryl sulfate toothpaste, which quench the antiseptic

Serious adverse effects

  • Hypersensitivity reactions, including anaphylactic ones
  • Laryngospasm
  • Sensitization with prolonged use

Common adverse effects

  • Burning of the mouth lining
  • Dry mouth
  • Unpleasant taste
  • Nausea

Pregnancy: can you take Cetylpyridinium?

Data on cetylpyridinium and benzydamine in pregnancy are absent or limited. Combination lozenges are not recommended during pregnancy.

Breastfeeding: can you take Cetylpyridinium?

Whether cetylpyridinium and its metabolites pass into breast milk is unknown. A risk to the infant cannot be excluded, so the decision on treatment or on continuing to breastfeed is made separately.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Cetylpyridinium used for?

Cetylpyridinium is evaluated for the following indications with varying evidence strength: Sore throat (evidence tier C), Immune support and respiratory infection care (evidence tier F), COVID-19 prevention (evidence tier F). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Cetylpyridinium?

Common side effects of Cetylpyridinium (≥ 1 in 100): Burning of the mouth lining, Dry mouth, Unpleasant taste, Nausea. See the Safety section for uncommon and serious reactions.

Is Cetylpyridinium safe during pregnancy?

Data on cetylpyridinium and benzydamine in pregnancy are absent or limited. Combination lozenges are not recommended during pregnancy.

Is Cetylpyridinium compatible with breastfeeding?

Whether cetylpyridinium and its metabolites pass into breast milk is unknown. A risk to the infant cannot be excluded, so the decision on treatment or on continuing to breastfeed is made separately.

Who should not take Cetylpyridinium?

Cetylpyridinium is contraindicated in: Hypersensitivity to cetylpyridinium; Children under 6 years because of the dosage form; Concurrent use with anionic compounds, for example lauryl sulfate toothpaste, which quench the antiseptic. Full list in the Safety section.

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Benzydamine, Flurbiprofen, Imudon (polyvalent bacterial lysate)